Anti-CD20 monoclonal antibody therapy for autoimmune hemolytic anemia following T cell-depleted, haplo-identical stem cell transplantation
Open Access
- 1 February 2002
- journal article
- other
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 29 (4) , 365-366
- https://doi.org/10.1038/sj.bmt.1703371
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Autoimmune hemolytic anemia in patients with SCID after T cell-depleted BM and PBSC transplantationBone Marrow Transplantation, 1999
- Overview of the clinical development of rituximab: first monoclonal antibody approved for the treatment of lymphoma.1999
- Rituxan in the treatment of cold agglutinin disease.1998
- Treatment of High-Risk Acute Leukemia with T-Cell–Depleted Stem Cells from Related Donors with One Fully Mismatched HLA HaplotypeNew England Journal of Medicine, 1998
- Late onset haemolysis and red cell autoimmunisation after allogeneic bone marrow transplantBone Marrow Transplantation, 1997
- Autoimmune hemolytic anemia following T cell-depleted allogeneic bone marrow transplantation.1996
- Immunoglobulin synthesis and generalized autoimmunity in mice congenitally deficient in αβ(+) T cellsNature, 1994
- Immunohematologic complications of bone marrow transplantation.1991
- Autoimmune pancytopenia following allogeneic bone marrow transplantation.1990
- DONOR-DERIVED RED-BLOOD-CELL ANTIBODIES AND IMMUNE HEMOLYSIS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION1986